
Voglimit 0.2 Tablet
Marketer
Vaks Pharma
Salt Composition
Voglibose (0.2mg)
Overview Voglimit 0.2 Tablet
Voglibose 0.2mg tablets are prescribed for managing type 2 diabetes. This medication assists in regulating elevated blood glucose post-meal. It's employed when dietary modifications and other comparable medications prove insufficient in controlling hyperglycemia. Administer Voglibose 0.2mg immediately before meals. Dosage and frequency are determined by your physician to optimize blood sugar management. Discontinue use only under your doctor's guidance; abrupt cessation may elevate blood sugar, potentially causing severe complications such as renal impairment and vision loss. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, physical activity, and weight management as directed by your healthcare provider. Regular blood glucose monitoring is crucial while using this medicine. Common adverse reactions may include intestinal gas, abdominal discomfort, anorexia, constipation, and diarrhea. Report any persistent or bothersome side effects to your doctor. While Voglibose doesn't independently induce hypoglycemia, concurrent use with other antidiabetic agents (especially insulin or sulfonylureas) can increase this risk. Treat hypoglycemic episodes with pure glucose; sucrose is ineffective in this context. Inform your physician of any pre-existing kidney or liver conditions before commencing treatment. Avoid this medication if you have bowel inflammation or ulceration (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating individuals should seek medical advice prior to use. Ensure your physician is aware of all other medications you are currently taking. Limit alcohol consumption while taking this medicine to reduce the hypoglycemia risk.
Uses of Voglimit 0.2 Tablet
Managing type 2 diabetes
Major Benefits of Voglimit 0.2 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglimit 0.2mg tablets should be taken on an empty stomach.
Common Side effects of Voglimit 0.2 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglimit 0.2 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglimit 0.2 Tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
How Voglimit 0.2 Tablet works:
Voglimit 0.2mg tablets are used to manage diabetes. Their mechanism of action involves blocking the digestive enzymes that process complex carbohydrates, thereby limiting the rapid postprandial surge in blood glucose.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglimit 0.2 Tablet and alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Voglimit 0.2 Tablet during pregnancy is typically regarded as safe. Preclinical trials in animals have indicated minimal or no harmful consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Voglimit 0.2 Tablet safely. Available human data indicates minimal infant risk associated with this medication.
DrivingSAFE
Driving ability is typically unaffected by Voglimit 0.2 Tablet.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Voglimit 0.2 Tablets, as dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Voglimit 0.2 Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Voglimit 0.2 Tablet :
Omit any missed Voglimit 0.2 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Voglimit 0.2 Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Good Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |
